Aprogen Biologics Inc. (KRX:003060)
South Korea · Delayed Price · Currency is KRW 515.00
0.00 (0.00%)
At close: Jan 9, 2026
Aprogen Biologics Market Cap
Aprogen Biologics has a market cap or net worth of 101.75 billion as of January 9, 2026. Its market cap has decreased by -22.21% in one year.
Market Cap
101.75B
Enterprise Value
317.79B
Revenue
74.91B
Ranking
n/a
PE Ratio
n/a
Stock Price
515.00
Market Cap Chart
Since January 5, 1996, Aprogen Biologics's market cap has increased from 3.18B to 101.75B, an increase of 3,099.11%. That is a compound annual growth rate of 12.23%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 8, 2026 | 101.75B | -0.77% |
| Dec 30, 2025 | 102.54B | -21.60% |
| Dec 30, 2024 | 130.79B | -31.41% |
| Dec 28, 2023 | 190.68B | -4.89% |
| Dec 29, 2022 | 200.48B | -44.42% |
| Dec 30, 2021 | 360.71B | -31.18% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Samsung Biologics | 79.67T |
| Celltrion | 46.60T |
| ALTEOGEN | 25.35T |
| ABL Bio | 11.08T |
| SK Biopharmaceuticals | 9.85T |
| Yuhan | 8.55T |
| HLB Co., Ltd. | 7.19T |
| LigaChem Biosciences | 6.38T |